Ventyx Biosciences Inc (VTYX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Raju S. Mohan
Employees:
30
662 ENCINITAS BLVD., STE. 250, ENCINITAS, CA 92024
(858) 945-2393

Ventyx Biosciences, Inc. develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus.

Data derived from most recent annual or quarterly report
Market Cap 1.4 Billion Shares Outstanding50.91 Million Avg 30-day Volume 401.857 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3.17
Price to Revenue0.0 Debt to Equity0.0 EBITDA-90.887 Million
Price to Book Value4.7029 Operating Margin0.0 Enterprise Value1.391 Billion
Current Ratio11.732 EPS Growth0 Quick Ratio11.565
1 Yr BETA 1.4489 52-week High/Low 41.29 / 9.5 Profit Margin0.0
Operating Cash Flow Growth-156.0597 Altman Z-Score29.0615 Free Cash Flow to Firm 0
View SEC Filings from VTYX instead.

View recent insider trading info

Funds Holding VTYX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VTYX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    7.9 Thousand total shares from 2 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SUBRAMANIAM SOMU

    • Director
    • 10% Owner
    16,888,593 2022-11-07 2

    NSV PARTNERS III LP

    NSV PARTNERS III GP LLC

    • 10% Owner
    16,888,593 2022-11-07 1

    KRUEGER CHRISTOPHER W CHIEF BUSINESS OFFICER

    • Officer
    376,887 2022-08-23 3

    VENBIO GLOBAL STRATEGIC FUND III, L.P.

    VENBIO GLOBAL STRATEGIC GP III, L.P.

    VENBIO GLOBAL STRATEGIC GP III, LTD

    ADELMAN ROBERT J

    GOODMAN COREY S

    • 10% Owner
    • SEE REMARKS
    13,301 2022-06-09 1

    GUJRATHI SHEILA

    • Director
    13,301 2022-06-09 2

    ROYSTON AARON

    • Director
    13,301 2022-06-09 1

    WHITE WILLIAM RICHARD

    • Director
    13,301 2022-06-09 1

    GASTER RICHARD

    • Director
    13,301 2022-06-09 1

    CHOKSEY JIGAR

    • Director
    0 2022-06-09 2

    SANDBORN WILLIAM J. SEE REMARKS

    • Officer
    83,266 2022-05-09 2

    DRAPPA JORN CHIEF MEDICAL OFFICER

    • Officer
    145,000 2022-02-04 1

    NUSS JOHN CHIEF SCIENTIFIC OFFICER

    • Officer
    145,000 2022-02-04 2

    AUSTER MARTIN CHIEF FINANCIAL OFFICER

    • Officer
    145,000 2022-02-04 1

    MOHAN RAJU CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    370,000 2022-02-04 2

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND III LP

    • 10% Owner
    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    2,195,606 2021-10-25 0

    NSV INVESTMENTS I, L.P.

    NSV PARTNERS III LP

    NSV PARTNERS III GP LLC

    • 10% Owner
    16,892,528 2021-10-25 0

    NSV INVESTMENTS I, L.P.

    • 10% Owner
    0 2021-10-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SUBRAMANIAM SOMU - Director - > 10% Owner see footnotes

    2022-11-09 17:05:11 -0500 2022-11-07 S 3,935 $29.08 d 16,888,593 indirect 1.0286 -5.1048 1.0286 2 -5.1048 6

    NSV PARTNERS III LP - > 10% Owner see footnotes

    NSV PARTNERS III GP LLC - > 10% Owner see footnotes

    2022-11-09 18:32:42 -0500 2022-11-07 S 3,935 $29.08 d 16,888,593 indirect 1.0286 -5.1048 1.0286 2 -5.1048 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 22:15:03 UTC 0.5658 3.2542 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 21:45:04 UTC 0.5658 3.2542 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 21:15:03 UTC 0.5658 3.2542 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 20:45:03 UTC 0.5658 3.2542 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 20:15:03 UTC 0.5658 3.2542 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 19:45:04 UTC 0.5658 3.2542 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 19:15:03 UTC 0.5658 3.2542 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 18:45:03 UTC 0.6333 3.1867 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 18:15:03 UTC 0.6333 3.1867 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 17:45:04 UTC 0.6333 3.1867 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 17:15:03 UTC 0.6333 3.1867 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 16:45:04 UTC -0.2575 4.0775 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 16:15:03 UTC -0.2575 4.0775 300000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 15:45:03 UTC -0.2575 4.0775 250000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 15:15:03 UTC -0.2575 4.0775 250000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 14:45:04 UTC -0.2575 4.0775 250000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 14:15:04 UTC -0.2575 4.0775 250000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 13:45:03 UTC 0.2537 3.5663 250000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 13:15:03 UTC 0.2537 3.5663 200000
    VENTYX BIOSCIENCES INC VTYX 2022-11-25 12:45:03 UTC 0.2537 3.5663 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund VTYX -3854.0 shares, $-47134.42 2022-06-30 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund VTYX -517.0 shares, $-7811.87 2022-07-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments